Pathstone Family Office’s Healthpeak Properties DOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$347K Buy
18,801
+2,919
+18% +$59.9K ﹤0.01% 1223
2023
Q2
$321K Sell
15,882
-4,145
-21% -$86.1K ﹤0.01% 940
2023
Q1
$444K Sell
20,027
-38,807
-66% -$962K 0.01% 747
2022
Q4
$1.41M Buy
58,834
+15,155
+35% +$368K 0.01% 618
2022
Q3
$1M Buy
43,679
+28,327
+185% +$748K 0.01% 739
2022
Q2
$397K Sell
15,352
-239
-2% -$7.24K 0.01% 674
2022
Q1
$538K Sell
15,591
-72
-0.5% -$2.42K 0.01% 521
2021
Q4
$566K Buy
15,663
+59
+0.4% +$2.04K 0.01% 512
2021
Q3
$523K Buy
15,604
+1,265
+9% +$44.8K 0.02% 497
2021
Q2
$477K Buy
14,339
+4,302
+43% +$144K 0.01% 482
2021
Q1
$319K Buy
10,037
+7,329
+271% +$223K 0.01% 469
2020
Q4
$82K Buy
+2,708
New +$78.8K ﹤0.01% 426
2014
Q1
Sell
-79
Closed -$3K 203
2013
Q4
$3K Buy
+79
New +$2.82K 0.01% 180

Other funds holding DOC

Pathstone Family Office's DOC Position: Q3 2023 in Review

Pathstone Family Office increased its Healthpeak Properties (DOC) stake by 18% in Q3 2023, buying an estimated $59.9K and bringing the position to 18,801 shares worth $347K. The position accounts for ﹤0.01% of the portfolio, ranked #1223.

Pathstone Family Office first reported a position in DOC in Q4 2013 and has held it in 13 quarters since. The position peaked at $1.41M in Q4 2022. 585 funds tracked by Wall St. Rank hold DOC as of Q3 2023.

  • Pathstone Family Office held 18,801 shares of Healthpeak Properties worth $347K as of Q3 2023.
  • Pathstone Family Office bought 2,919 Healthpeak Properties shares in Q3 2023, an estimated $59.9K.
  • Healthpeak Properties made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1223 holding.
  • Pathstone Family Office first reported a position in Healthpeak Properties in Q4 2013 and has held it in 13 quarters since.
  • Pathstone Family Office's Healthpeak Properties position peaked at $1.41M in Q4 2022.
  • 585 funds tracked by Wall St. Rank held Healthpeak Properties as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.